How Financial Interests Shaped American Dietary Policy: A Historical Account of Institutional Bias, Junk Science, and the Vilification of Saturated Fat Historical Perspective Chapter —

How Financial Interests Shaped American Dietary Policy:
A Historical Account of Institutional Bias, Junk Science, and the Vilification of Saturated Fat

Historical Perspective Chapter — Draft for Peer Review

To understand how nutritional science became captured by financial interests, one must begin not with a dietitian or a cardiologist, but with a man who held no medical degree whatsoever. Abraham Flexner was an educational reformer commissioned in 1908 by the Carnegie Foundation for the Advancement of Teaching — an institution funded substantially by John D. Rockefeller — to survey American medical schools and produce recommendations for reform. His 1910 report, formally titled “Medical Education in the United States and Canada,” would become one of the most consequential documents in the history of American medicine.

On its surface, the Flexner Report sought to professionalize medical education by establishing rigorous scientific standards. Many of the 155 schools it evaluated were indeed poorly organized and lacked basic laboratory infrastructure. However, the report’s deeper effect — and arguably its intended effect — was to consolidate control over what constituted legitimate medicine. Schools that incorporated naturopathy, homeopathy, herbal medicine, nutrition, and eclectic traditions were systematically downgraded or condemned. Within two decades of the report’s publication, the number of medical schools in the United States fell from 155 to 31. Hundreds of practitioners trained in these traditions lost their livelihoods, and entire bodies of knowledge were effectively erased from the mainstream medical curriculum.

The financial mechanics of this transformation are critical to understand. Rockefeller’s philanthropic apparatus — including the General Education Board, which disbursed tens of millions of dollars in grants — directed funding preferentially to schools aligned with pharmaceutical and laboratory-based medicine. This was not incidental: Rockefeller had enormous financial interests in the petrochemical and pharmaceutical industries. A medical establishment oriented toward synthetic drugs rather than nutrition, botanicals, and lifestyle interventions was directly aligned with those interests. The Flexner Report provided the intellectual and institutional architecture to achieve that alignment, legitimizing it under the banner of scientific rigor.

The consequences for nutritional medicine were severe and long-lasting. By the mid-20th century, medical school curricula devoted negligible time to nutrition — a pattern that persists to the present day, with surveys consistently showing that American medical students receive fewer than 20 hours of nutritional education across four years of training. The foundational premise was set early: food was background noise; drugs were medicine.

It is essential to note that this critique does not imply that the professionalization of medicine was without benefit — germ theory, sterile technique, and laboratory diagnostics have unambiguously saved lives. The problem was not reform itself, but who controlled the reform, and what was systematically excluded in the process.

No single figure looms larger in the history of the diet-heart hypothesis than Ancel Keys, a physiologist at the University of Minnesota whose influence over American nutritional policy from the 1950s through the 1980s was arguably unrivaled. Keys was a formidable scientist and an equally formidable political operator — and the distinction between those two roles became dangerously blurred in his most important work.

The story properly begins not with the Seven Countries Study but with an earlier analysis Keys published in 1953, in which he plotted dietary fat intake against coronary heart disease mortality across six countries and reported a striking correlation. The graph appeared to confirm a straightforward relationship: more fat, more heart disease. What Keys omitted from that analysis — and what his critics noted at the time — was that data were available from 22 countries. When all 22 were included, the correlation largely dissolved. Keys had, whether by design or selective judgment, published only the data that supported his hypothesis.

His larger and more formally designed Seven Countries Study, initiated in the late 1950s and published in full in 1980, examined cardiovascular disease rates across cohorts in the United States, Finland, the Netherlands, Italy, Greece, Yugoslavia, and Japan. It became the empirical foundation for the diet-heart hypothesis. Yet the study’s methodological limitations were substantial and well-documented. Country selection was not random — Keys chose nations that fit his anticipated results. Dietary data collection was inconsistent across cohorts. Confounding variables including smoking rates, physical activity, socioeconomic status, and overall dietary patterns were inadequately controlled. Perhaps most critically, Keys conflated total fat with saturated fat, obscuring the question of which dietary component, if any, was actually relevant.

British nutritionist John Yudkin posed the most direct scientific challenge to Keys. Yudkin’s research in the 1960s and 1970s built a compelling case that refined sugar — not saturated fat — was the primary dietary driver of cardiovascular disease and metabolic dysfunction. His 1972 book “Pure, White and Deadly” presented this evidence accessibly and forcefully. Keys’s response was not primarily scientific — it was personal and institutional. He attacked Yudkin’s methodology and character in terms that went well beyond academic debate, calling his work “a mountain of nonsense” and labeling him a shill for the meat and dairy industries. Yudkin’s reputation suffered significantly; his work was marginalized for decades. It was not until Cristin Kearns and her colleagues published their archival research in JAMA Internal Medicine in 2016 that the full dimensions of what had been done to suppress the sugar hypothesis became publicly documented.

Share

Among the most troubling episodes in this history is the fate of the Minnesota Coronary Experiment, a randomized controlled trial conducted by Ancel Keys and Ivan Frantz between 1968 and 1973. The trial enrolled over 9,000 institutionalized patients — residents of state mental hospitals and a nursing home — and randomized them to either a diet high in saturated fat (primarily from animal products) or a diet in which saturated fat was replaced by vegetable oils rich in linoleic acid (a polyunsaturated omega-6 fatty acid). The intervention successfully lowered serum cholesterol in the treatment group, consistent with the prevailing hypothesis.

What the intervention did not do was reduce cardiovascular events or mortality. In fact, analysis of the recovered data — which was not published until 2016, over four decades after the trial concluded, when recovered data were reanalyzed by Christopher Ramsden and colleagues at the National Institutes of Health and published in the BMJ — revealed a troubling signal: for every 30 mg/dL reduction in serum cholesterol achieved through dietary modification, all-cause mortality increased by approximately 22%. Participants in the intervention group who successfully lowered their cholesterol had higher, not lower, mortality rates.

Why were these results not published contemporaneously? The trial’s principal investigators did not offer a complete explanation, and Frantz, who died in 2009, left no definitive account. The recovered data were found in a storage unit by the son of a co-investigator. Whatever the reason, the suppression — intentional or otherwise — meant that a large, well-powered randomized trial producing results that contradicted the diet-heart hypothesis remained unknown to the scientific community during the decades when dietary policy was being most actively shaped.

The Ramsden reanalysis, published in the BMJ in 2016, concluded that the available evidence did not support the hypothesis that replacing saturated fat with vegetable oil would reduce coronary heart disease events or all-cause mortality. This conclusion, based on recovered data from one of the largest dietary randomized trials ever conducted, received considerably less public attention than the original hypothesis it challenged.

In 2016, Cristin Kearns, Stanton Glantz, and Laura Schmidt published a landmark paper in JAMA Internal Medicine documenting what archival research in the collections of the Sugar Research Foundation (SRF), Harvard University, and the estate of a deceased industry scientist had revealed. The finding was stark: the sugar industry had secretly funded research designed to shift scientific and public attention away from sugar as a cause of cardiovascular disease and toward dietary fat.

The documents showed that in 1964, the SRF’s vice president, John Hickson, identified Yudkin’s sugar hypothesis as an existential threat to the industry and proposed a coordinated research program to counter it. The SRF subsequently funded a 1967 literature review published in the New England Journal of Medicine — then as now one of the most prestigious medical journals in the world — that reviewed the evidence on diet and heart disease and reached conclusions favorable to the fat hypothesis while downplaying evidence implicating sugar. The three authors of that review — D. Mark Hegsted, Robert McGandy, and Fredrick Stare, all of Harvard — did not disclose their funding from the SRF. Hickson had reviewed and commented on the manuscript before publication.

The consequences extended far beyond a single journal article. Hegsted went on to become the head of nutrition at the USDA, where he played a central role in drafting the 1977 Dietary Goals for the United States — the McGovern Report — which established the low-fat dietary paradigm that would govern American nutritional policy for the following four decades. The intellectual lineage from industry funding to published science to federal policy is, in this case, unusually direct and unusually well-documented.

The JAMA Internal Medicine authors concluded that industry-funded nutrition research should be treated with the same scrutiny applied to pharmaceutical industry research — a standard of transparency and conflict-of-interest disclosure that the nutrition field had, until recently, largely failed to apply to itself.

The 1977 Dietary Goals for the United States, produced by the Senate Select Committee on Nutrition and Human Needs under Senator George McGovern, marked the formal entry of the federal government into nutritional prescription. For the first time, Americans were given explicit quantitative targets: reduce total fat intake to 30% of calories, reduce saturated fat to 10%, reduce dietary cholesterol, and increase carbohydrate consumption to 55–60% of calories.

The scientific basis for these recommendations was, at the time of their adoption, contested. Several prominent scientists — including Pete Ahrens of Rockefeller University and the epidemiologist Michael Pariza — objected that the evidence was insufficient to support population-wide dietary prescriptions. Their objections were noted and disregarded. The cattle and egg industries lobbied strenuously against the guidelines; in response, the language was softened from “reduce consumption of meat” to “choose meats, poultry, and fish that will reduce saturated fat intake” — a political rather than scientific modification.

The downstream effects of the low-fat guidelines are now extensively documented in the epidemiological record, though causation remains debated. As Americans reduced their fat consumption over the following decades — and the food industry responded with a proliferation of low-fat, high-sugar, high-refined-carbohydrate products — rates of obesity, type 2 diabetes, and metabolic syndrome rose sharply. When fat is removed from food, palatability suffers; the food industry compensated with sugar, high-fructose corn syrup, refined starches, and additives. The substitution was never explicitly recommended by the guidelines, but it was an entirely predictable consequence of them.

The institutional relationship between the American Heart Association and the food industry has deep roots that are rarely examined in mainstream discussions of cardiovascular risk. In 1948, Procter & Gamble donated $1.5 million to the AHA — at the time an organization of modest means — essentially underwriting its national expansion. Procter & Gamble was, at that moment, the manufacturer of Crisco, a partially hydrogenated vegetable shortening introduced in 1911 as a cheaper alternative to lard and butter. The product was made from cottonseed oil and later soybean oil — precisely the category of fats that the AHA would subsequently recommend as heart-healthy alternatives to saturated animal fats.

The AHA’s 1961 endorsement of polyunsaturated vegetable oils as preferable to saturated fats — the first such statement from a major medical organization — was published as a monograph in Circulation. It drew heavily on Keys’s work. The organization has maintained and periodically strengthened this recommendation ever since, while continuing to receive substantial funding from food and pharmaceutical industry sources. The alignment between the AHA’s dietary recommendations and the commercial interests of its major donors has been a persistent feature of its institutional history.

The seed oils in question — soybean, corn, cottonseed, sunflower, safflower, and canola oils — are produced through industrial processes that include high-temperature extraction, solvent treatment (typically hexane), bleaching, and deodorization. They are rich in linoleic acid, an omega-6 polyunsaturated fatty acid. While polyunsaturated fats do lower LDL cholesterol in controlled feeding studies, the metabolic consequences of consuming these oils in the quantities now present in the Western diet are a matter of active scientific investigation and legitimate concern.

Linoleic acid is highly susceptible to oxidation, both during high-temperature processing and cooking, and potentially within the body following consumption. Oxidized linoleic acid metabolites (OXLAMs) have been associated with inflammatory processes, and the dramatic shift in the ratio of dietary omega-6 to omega-3 fatty acids over the 20th century — from an estimated ancestral ratio of approximately 1:1 to the current Western ratio of roughly 15–20:1 — is hypothesized by some researchers to be a significant contributor to chronic inflammatory disease. The evidence base for this hypothesis is growing; what is clear is that the promotion of seed oils as “heart-healthy” occurred decades before these metabolic questions were adequately investigated.

The Food Additives Amendment of 1958 introduced a provision into federal food safety law that would, over the following decades, create one of the most consequential regulatory loopholes in the history of consumer protection. The amendment required manufacturers to demonstrate the safety of new food additives before marketing — a reasonable requirement that represented a genuine advance in food safety regulation. However, it included an exemption for substances “generally recognized as safe” (GRAS) by qualified experts based on scientific procedures or, for substances used prior to 1958, by common use in food.

The exemption was initially intended to cover obviously safe substances with long histories of use — salt, sugar, vinegar. Over time, through regulatory interpretation and industry pressure, it evolved into something far more permissive. The FDA does not require manufacturers to notify the agency before marketing a substance under a GRAS designation, and — critically — companies are permitted to make GRAS determinations themselves, using experts of their own selection, without independent review. A 2010 Government Accountability Office report found that the FDA’s oversight of the GRAS process was inadequate and that the agency often had no knowledge that a substance was being used in food.

The practical result is that thousands of substances have entered the American food supply under self-certified GRAS designations, with safety evaluations conducted by panels whose members are selected and compensated by the manufacturers seeking approval. A 2013 study in JAMA Internal Medicine examined 222 GRAS notifications to the FDA and found that not a single one was made by an independent panel — all involved experts with direct financial relationships to the manufacturer. This is not a system of independent scientific review; it is a system of institutionalized conflict of interest embedded in federal law.

Industrial seed oils, trans fats (partially hydrogenated vegetable oils), and numerous other processed food ingredients entered widespread use under GRAS designations before their long-term metabolic effects were understood. Trans fats — eventually recognized as definitively harmful and banned by the FDA in 2018 — spent decades in the food supply under GRAS protection, recommended as healthy alternatives to saturated fat, in part because they lowered LDL cholesterol in short-term feeding studies. The lesson was not applied to other seed oil components whose long-term effects remain under investigation.

Share The Rancher Doctor Newsletter

Beginning in the late 1980s and accelerating through the 1990s, the major tobacco companies — facing mounting litigation, declining domestic cigarette sales, and tightening regulation — undertook a strategic diversification into the food industry. Philip Morris acquired General Foods in 1985 and Kraft in 1988, eventually merging them into Kraft General Foods, at the time the largest food company in the United States. RJR Nabisco, formed by the merger of R.J. Reynolds Tobacco and Nabisco Brands in 1985, brought together the manufacturer of Camel cigarettes and the maker of Oreos, Ritz crackers, and Chips Ahoy. These were not passive investments; they represented the application of tobacco industry expertise to a new consumer product category.

The tobacco industry had spent decades developing sophisticated scientific and psychological frameworks for maximizing addictive potential and sustaining consumption behavior. The scientific tools developed to understand and exploit nicotine addiction — studies of bliss points, reward pathway activation, sensory-specific satiety, and the neurological mechanisms of craving — were directly applicable to food product development. Researchers who had worked on tobacco addiction and the suppression of smoking cessation were brought into food product development roles.

The concept of the “bliss point” — the precise combination of sugar, fat, and salt that produces maximum hedonic response and minimizes satiety signals — was not invented by the tobacco-owned food companies, but it was refined and industrialized under their ownership. Michael Moss’s extensively documented 2013 book “Salt Sugar Fat: How the Food Giants Hooked Us” drew on internal industry documents and interviews with former food scientists to describe a product development process explicitly oriented toward override of the neurological stop signals that regulate appetite.

The result was a generation of hyperpalatable processed food products engineered to produce consumption that exceeded physiological need — products that activated reward pathways in ways that, in vulnerable individuals, bore meaningful resemblance to the mechanisms of substance dependence. The science of addiction, developed in service of one public health catastrophe, was systematically applied to creating another.

These events did not occur in isolation; they formed an interconnected causal chain that shaped American dietary policy over more than a century. The Flexner Report eliminated nutrition from medical training, ensuring that physicians would have neither the knowledge nor the institutional incentive to challenge dietary orthodoxy. Rockefeller and Carnegie funding shaped which research programs received support. Ancel Keys’s cherry-picked epidemiology established the saturated fat hypothesis as consensus. Sugar industry money corrupted the peer-reviewed literature and shaped the careers of researchers who would write federal dietary guidelines. The AHA, institutionally dependent on industry funding, became the authoritative endorser of the vegetable oil paradigm. The GRAS loophole allowed novel industrial food ingredients to enter the food supply without independent safety review. And tobacco-trained scientists applied the science of addiction to processed food manufacturing.

The dietary guidelines built on this foundation have been associated —temporally and epidemiologically associated — with one of the most dramatic rises in chronic metabolic disease in recorded history. Since the publication of the 1977 McGovern Report, rates of obesity in the United States have roughly tripled. The prevalence of type 2 diabetes has increased more than fourfold. Metabolic syndrome, a constellation of risk factors including central obesity, hypertriglyceridemia, low HDL, elevated fasting glucose, and hypertension, now affects an estimated one-third of American adults.

Multiple factors — declining physical activity, urbanization, socioeconomic changes, environmental exposures — have co-occurred with the dietary shifts of the past half-century. The argument is not that dietary guidelines alone caused the epidemic of metabolic disease. The argument is that the guidelines were built on a compromised scientific foundation, that the financial interests shaping that foundation were never adequately disclosed or regulated, and that the resulting policy experiment — conducted on an entire population without informed consent — has at minimum failed to prevent the chronic disease epidemic it was designed to address, and may have contributed heavily to it.

The scientific case against the saturated fat hypothesis has grown substantially over the past two decades, with meta-analyses and systematic reviews that would have been impossible in Yudkin’s time now providing high-level evidence against the foundational assumptions of decades of dietary policy.

Siri-Tarino and colleagues’ 2010 meta-analysis in the American Journal of Clinical Nutrition, which pooled data from 21 prospective cohort studies involving nearly 350,000 subjects, found no significant association between saturated fat intake and cardiovascular disease, coronary heart disease, or stroke. Chowdhury and colleagues’ 2014 meta-analysis in the Annals of Internal Medicine, examining data from 72 studies with over 600,000 participants, reached similar conclusions. The PURE (Prospective Urban Rural Epidemiology) study, published in the Lancet in 2017 and encompassing over 135,000 individuals across 18 countries, found that higher fat intake — including saturated fat — was associated with lower mortality, while high carbohydrate intake was associated with higher mortality.

The LDL picture is more nuanced than the diet-heart hypothesis assumed. Saturated fat does raise LDL cholesterol, but it raises it by increasing the concentration of large, buoyant LDL particles — the phenotype associated with lower cardiovascular risk — rather than small, dense LDL particles, which are more strongly associated with atherosclerotic disease. It also raises HDL cholesterol, the lipoprotein associated with cardiovascular protection. The net effect on cardiovascular risk biomarkers is not the straightforwardly harmful profile the hypothesis predicts.

None of this vindicates every food marketed as containing saturated fat, nor does it suggest that dietary pattern is irrelevant to cardiovascular health. It does suggest, however, that the singular focus on saturated fat as the dietary villain of cardiovascular disease — a focus that shaped a half-century of policy, clinical advice, food manufacturing, and public behavior — was built on a foundation that has not survived rigorous scientific scrutiny.

The history surveyed in this chapter is not a history of inevitable scientific error — mistakes are intrinsic to the scientific enterprise, and the gradual self-correction of error is science functioning as intended. It is a history of institutional capture: of research funding structured to produce predetermined conclusions, of peer review subverted by undisclosed conflicts of interest, of regulatory frameworks designed — or evolved — to serve the industries they were meant to oversee, and of the resulting policy landscape imposed on a population that had no mechanism for meaningful consent.

The lessons for contemporary evidence-based medicine are uncomfortable but necessary. Systematic reviews and meta-analyses are only as valid as the primary studies from which they draw their data; if those studies were funded and conducted under conditions of conflicts of interest that biased their results, the downstream synthesis inherits those biases. Institutional endorsement — by the AHA, the USDA, the NIH, or any other authority — confers credibility that may exceed what the underlying evidence warrants. And the history of the diet-heart hypothesis demonstrates that an idea can be simultaneously dominant in institutional medicine, embedded in federal policy, endorsed by major professional organizations, and substantially incorrect.

Scientific humility — the acknowledgment that the current consensus may be as wrong as past consensuses have been — is not a concession to anti-science sentiment. It is the appropriate epistemological posture for a field that has, within living memory, been demonstrably wrong about ulcers, hormone replacement therapy, dietary fat, and the safe level of sugar consumption. Clinicians who bring that humility to the interpretation of nutritional evidence, and who remain open to challenges from the peer-reviewed literature regardless of their institutional source, are practicing evidence-based medicine in its most rigorous sense.

The rehabilitation of beef and other whole animal foods as part of a nutritionally sound dietary pattern is not nostalgia or ideology. It is the application of that humility — and of an expanding evidence base — to one of the most consequential and most corrupted questions in the history of public health.

· Flexner A. Medical Education in the United States and Canada. Carnegie Foundation for the Advancement of Teaching, Bulletin No. 4, 1910.

· Keys A. Atherosclerosis: a problem in newer public health. J Mt Sinai Hosp N Y. 1953;20(2):118-139.

· Keys A et al. The Seven Countries Study: A multivariate analysis of death and coronary heart disease. Harvard University Press, 1980.

· Yudkin J. Pure, White and Deadly. Davis-Poynter Ltd, London, 1972.

· Ramsden CE et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968–73). BMJ. 2016;353:i1246.

· Kearns CE, Schmidt LA, Glantz SA. Sugar industry and coronary heart disease research: a historical analysis of internal industry documents. JAMA Intern Med. 2016;176(11):1680-1685.

· Siri-Tarino PW et al. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91(3):535-546.

· Chowdhury R et al. Association of dietary, circulating, and supplement fatty acids with coronary risk. Ann Intern Med. 2014;160(6):398-406.

· Dehghan M et al. (PURE Study). Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries. Lancet. 2017;390(10107):2050-2062.

· Moss M. Salt Sugar Fat: How the Food Giants Hooked Us. Random House, 2013.

· U.S. Government Accountability Office. Food Safety: FDA Should Strengthen Its Oversight of Food Ingredients Determined to Be Generally Recognized as Safe (GRAS). GAO-10-246. 2010.

Share

Leave a comment